Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 10mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 10mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 20mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 20mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 30mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 30mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 40mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 40mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 60mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 60mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leveraxo 80mg modified-release tablets
viatris uk healthcare ltd - oxycodone hydrochloride - modified-release tablet - 80mg
Ujerumani -
Kiingereza -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
methylphenidathydrochlorid develco pharma 18 mg retardtabletten
Ujerumani -
Kiingereza -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
methylphenidathydrochlorid develco pharma 36 mg retardtabletten
Ujerumani -
Kiingereza -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
methylphenidathydrochlorid develco pharma 54 mg retardtabletten
Israeli -
Kiingereza -
Ministry of Health
riavenir la 10 mg modified release capsules
bioavenir ltd, israel - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).